(S)-tert-Butyl 2-((S)-1-hydroxyethyl)piperazine-1-carboxylate

Catalog No.: 
ACPLQV619
CAS No.: 
1932146-94-5
Molecular Formula: 
C11H22N2O3
Molecular Weight: 
230.31
(S)-tert-Butyl 2-((S)-1-hydroxyethyl)piperazine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$356.00InquiryInquiry
100mg97%$546.00InquiryInquiry
250mg97%$849.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-tert-Butyl 2-((S)-1-hydroxyethyl)piperazine-1-carboxylate
IUPAC Nametert-butyl (S)-2-((S)-1-hydroxyethyl)piperazine-1-carboxylate
MDL No.MFCD26792472
Molecular FormulaC11H22N2O3
Molecular Weight230.31
SMILESC[C@@H]([C@H]1N(C(OC(C)(C)C)=O)CCNC1)O
InChI KeyLSGOFQGBDCLROP-IUCAKERBSA-N
Synonym(S)-1-Boc-2-((S)-1-hydroxyethyl)piperazine;1-Piperazinecarboxylic acid, 2-[(1S)-1-hydroxyethyl]-, 1,1-dimethylethyl ester, (2S)-;1,1-Dimethylethyl (2S)-2-[(1S)-1-hydroxyethyl]-1-piperazinecarboxylate;Tert-butyl (S)-2-((S)-1-hydroxyethyl)piperazine-1-carboxylate
CAS No.1932146-94-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACPLQV619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPLQV619 route product structure diagram
    ACPLQV6191932146-94-5
Inquiry

2. ACPLQV619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPLQV619 route product structure diagram
    ACPLQV6191932146-94-5
Inquiry

3. ACPLQV619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPLQV619 route product structure diagram
    ACPLQV6191932146-94-5
Inquiry

Comments (0)